Multidistrict litigation (MDL) is a consolidation of civil cases transferred from different jurisdictions around the country to a single U.S. District Court to achieve certain pre-trial efficiencies. All transferred cases must be marked by common fact questions, and are overseen by a federal judge. The aim of this consolidation is to preserve […]
Author: Searcy Law
Transvaginal mesh is a medical device implanted to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) in women. Transvaginal mesh is a semi-permeable barrier implanted into a woman as a reinforcing structure to keep her internal organs in place. The device is known as vaginal mesh because it is now […]
Transvaginal mesh was first developed from surgical mesh used in hernia repair surgeries since the 1950s. Traditionally, surgical mesh used for hernia repair was constructed of collagen extracted from bovine or human tissue and formed into a mesh that could be implanted in humans. Physicians used the same mesh to treat […]
In 2010, doctors in the United States inserted more than 70,000 mesh devices in patients, threading them through incisions in the vagina to fortify pelvic muscles that failed to support internal organs or to treat incontinence, according to court filings. Sometimes the failure of these devices is masked by other symptoms, pelvic […]
On January 9, 2015, the Department of Justice announced that Daiichi Sankyo, a Japanese corporation who has its United States headquarters in New Jersey, was fined $39 million as a result of violating the False Claims Act by paying kickbacks to physicians to induce them to prescribe drugs manufactured by […]
Antipsychotic Drugs Have Caused Breast Growth in Men More than two years after Johnson & Johnson settled a lawsuit with a 21-year-old man who experienced an adverse side effect from Risperdal, hundreds of other young male plaintiffs are pursuing claims for the same reason: unnatural breast growth. The condition […]
Daiichi Sankyo, Inc. developed the prescription medication Benicar (Olmesartan Medoxomil) to treat high blood pressure. In April 2002, the U.S. Food and Drug Administration (FDA) approved Benicar. Since that time, it has become a widely prescribed blood pressure medication. However, researchers have discovered Benicar use has a high association with […]
Male enhancement drugs might seem tempting to those with low testosterone and other erectile dysfunction issues, but the Food and Drug Administration is warning consumers that popping such pills is dangerous and possibly deadly. Between January and August of 2014, the federal agency issued 20 alerts, each targeting a different […]
In October of 2014, Endo International PLC (”Endo”) agreed to settle claims stemming from lawsuits that alleged problems with its vaginal mesh products. In the settlement, Endo asserts that the agreements are not an admission of liability. According to Bloomberg BusinessWeek, Endo agreed to pay “more than $400 million to […]
The Alabama Supreme Court in Wyeth v. Weeks has reaffirmed its ruling in a case questioning whether a brand-name drug maker can be held liable for injuries from a generic version. Plaintiffs Danny and Vicki Weeks sued drug manufacturers for injuries that Danny Weeks allegedly suffered as a result of […]
